Key Takeaways
- Shares of Rocket Lab climbed approximately 7% following a Buy rating reaffirmation from Cantor Fitzgerald
- The company’s June 22 entry into the Nasdaq-100 is viewed as a significant driver for passive institutional inflows
- KeyBanc initiated coverage with an Overweight rating and $135 target price, suggesting more than 30% upside
- Analysts attribute the recent price decline to portfolio rebalancing after SpaceX’s public market entry, not operational issues
- Consensus among Wall Street analysts stands at Strong Buy with a mean target of $108.70 and potential upside of 37%
Rocket Lab (RKLB) saw shares climb approximately 7% during Monday’s session following supportive commentary from two major Wall Street firms. Cantor Fitzgerald reaffirmed its bullish stance, while KeyBanc initiated coverage with an upgrade — providing a boost to a stock that had shed 11% just days earlier on June 12.
Shares remain approximately 27% below their 2024 peak reached in late May.
Andres Sheppard, analyst at Cantor Fitzgerald, emphasized June 22 as a pivotal milestone. On that date, Rocket Lab becomes an official component of the Nasdaq-100 Index. This elevation significantly increases visibility among institutional capital allocators and mandates purchases from index-tracking funds and exchange-traded products.
Sheppard characterized the Nasdaq-100 membership as “material” — a designation that appears well-founded given the expected buying pressure.
Beyond index mechanics, Sheppard identified several competitive advantages that distinguish Rocket Lab from emerging rivals. These strengths include an established history of reliable orbital missions, a diversified vehicle portfolio spanning Electron, HASTE, and the forthcoming Neutron platform, a balanced client mix across commercial and government sectors, and operational launch sites across New Zealand and the United States.
According to TipRanks, Sheppard ranks 1,456 among more than 12,200 tracked analysts, maintaining a perfect 100% success rate on RKLB calls with an impressive average one-year return of 196.92%.
KeyBanc Sees Opportunity in Recent Weakness
Michael Leshock of KeyBanc initiated coverage of RKLB with an Overweight stance and established a $135 price objective — suggesting potential gains exceeding 30% from the prior close. His investment case rests on the notion that recent price pressure stemmed from technical factors rather than deteriorating fundamentals.
Following SpaceX‘s landmark public market entry, portfolio managers rushed to establish positions in the newly accessible aerospace leader. This triggered a wave of selling across existing space sector holdings — Rocket Lab included. Leshock characterized this as rotation-driven volatility, not a reflection of company-specific concerns.
He highlighted a persistent structural gap between launch supply and demand that should persist beyond the next ten years. Accelerating deployment of satellite networks combined with expanding global military investment in space infrastructure reinforces this outlook.
Rocket Lab exited the first quarter with contractual commitments surpassing $2.2 billion. The company is also competing for prestigious opportunities including NASA’s Mars Telecommunications Orbiter initiative.
Manufacturing Control Provides Strategic Advantage
Leshock emphasized Rocket Lab’s vertically integrated operations as a critical competitive edge. With nearly 90 successful Electron flights completed and increasing disclosure around the Neutron medium-class vehicle development, he believes the organization demonstrates “institutional-grade” operational discipline.
He anticipates RKLB will avoid the pitfalls common among small-launch specialists by controlling more components of its value chain — an approach that echoes SpaceX’s proven strategic blueprint.
The investment community widely regards Rocket Lab as the undisputed second-place player in commercial space launch behind SpaceX.
Wall Street’s aggregate view on RKLB rates it a Strong Buy, derived from 10 Buy recommendations and three Hold ratings. The mean price objective stands at $108.70, while the most optimistic forecast reaches $150 — indicating approximately 37% appreciation potential from present levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
